Revelation Biosciences Insider Trades

REVB

Track insider trading activity from Revelation Biosciences executives and directors. See which insiders are buying and selling REVB stock.

Trades Last 12 Months

REVB Price

All Insider Trades for Revelation Biosciences

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Rolke James Chief Executive Officer
Holding Value $1.7M 422,814 shares
Last Trade
Aug 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$239k 208,076 shares
$1.15
$4.03
Carver Jennifer Director
Holding Value $180k 44,769 shares
Last Trade
Aug 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$36.8k 32,011 shares
$1.15
$4.03
Chawla Lakhmir S Director
Holding Value $178k 44,169 shares
Last Trade
Aug 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$36.8k 32,011 shares
$1.15
$4.03
Zygmont Chester Stanley Iii Chief Financial Officer
Holding Value $1.21M 300,136 shares
Last Trade
Aug 17, 2026 Purchase (Gift)Shares transferred as a gift rather than bought or sold for cash.
$239k 208,073 shares
$1.15
$4.03
Roper Jess Director
Holding Value $181k 44,839 shares
Last Trade
Aug 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$36.8k 32,011 shares
$1.15
$4.03
Zygmont Chester Stanley Iii Chief Financial Officer
Holding Value $371k 92,063 shares
Last Trade
Apr 30, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$14.6k 13,285 shares
$1.10
$4.03
Carver Jennifer Director
Holding Value $51.4k 12,758 shares
Last Trade
Feb 03, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.11k 1,661 shares
$1.87
$4.03
Roper Jess Director
Holding Value $51.7k 12,828 shares
Last Trade
Feb 03, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.94k 1,591 shares
$1.85
$4.03
Holding Value $1.08k 268 shares
Last Trade
Feb 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$700 181 shares
$3.87
$4.03
Labelle Curt H Director
Holding Value $25.6k 6,356 shares
Last Trade
Apr 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.63M 6,356 shares
$571.20
$4.03
Feis Lawrence 10% owner
Holding Value $0 0 shares
Last Trade
Jan 10, 2022 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$102B 731,950 shares
$139,776.00
$4.03
La Belle Curt H Director
Holding Value $0 0 shares
Last Trade
Jan 10, 2022 Sale
$12B 21,422 shares
$559,104.00
$4.03
Holding Value $1.54M 381,106 shares
Last Trade
Sep 23, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$414B 611,541 shares
$676,704.00
$4.03
Typaldos Andreas 10% owner, Chief Executive Officer
Holding Value $7.13M 1,769,538 shares
Last Trade
Dec 30, 2020 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$130B 192,962 shares
$673,344.00
$4.03
Fitzpatrick Sean H 10% owner, Chief Executive Officer
Holding Value $7.13M 1,769,538 shares
Last Trade
Dec 30, 2020 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$130B 192,962 shares
$673,344.00
$4.03

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up